The Modernization of Cosmetics Regulation Act (MoCRA) in the United States, set to take effect on December 29, is poised to bring significant changes to the production and sale of cosmetics within the country. MoCRA marks a groundbreaking step as the first comprehensive regulation in an industry that previously enjoyed relative freedom in production and sales due to the voluntary nature of cosmetic registrations.

Cosmetics, ranging from makeup and beauty products to skincare, shaving, body care, and hair products, are essential items consumed steadily and diversely regardless of age or gender. With the average U.S. consumer reportedly using a minimum of 6 to a maximum of 12 cosmetic products daily, the industry has gained substantial attention.

The enactment of MoCRA mandates facility and product registration, introducing a mandatory framework that was previously absent. This regulatory shift allows the U.S. Food and Drug Administration (FDA) to gain new insights into the multitude of products and their production locations within the U.S. beauty market. Additionally, MoCRA grants the FDA authority over aspects such as mandatory product recalls and warnings about allergen-inducing ingredients. Originally scheduled for full implementation on December 29, 2023, the FDA recently announced a six-month delay in the enforcement of certain provisions, garnering industry attention.

A pivotal aspect of MoCRA is the extension of the deadline for facility and product registrations to July 1, 2024, providing additional time for the industry to prepare for regulatory compliance. While this extension is welcomed by those navigating the complex landscape of MoCRA, it does not alleviate concerns entirely. Only the deadlines for facility and product registrations have been extended, leaving other regulations within MoCRA unaffected as of the original December 29, 2023 deadline.

MoCRA, a significant expansion of the FDA's regulatory authority over cosmetics, is the first of its kind since the passage of the Federal Food, Drug, and Cosmetic Act in 1938. While the majority of cosmetic industry entities welcome MoCRA as a necessary enhancement of regulatory oversight, there is notable confusion within the industry due to the lack of clear guidelines and representative compliance cases.

The voluntary nature of the previous FDA program, the Voluntary Cosmetic Registration Program (VCRP), allowed companies to operate without mandatory registration. However, ongoing consumer dissatisfaction and cases of harm related to cosmetic safety prompted the need for stronger regulations. The emergence of the "Clean Beauty" market, emphasizing safer ingredients, further highlighted the necessity for a regulatory update.

Despite the overall positive industry reception, uncertainties persist, especially among smaller brands and manufacturers. The central point of contention revolves around products designed for eye makeup. While MoCRA includes exemptions for certain conditions, such as businesses with an average annual cosmetic sales of less than $1 million over the past three years, the criteria for exemptions are causing confusion. Particularly, the ambiguity surrounding whether the exemption applies only to products directly contacting the mucous membrane of the eye or extends to traditional eye makeup products like mascara, eyeliner, and eyeshadow is a significant concern.

In conclusion, the 6-month extension in the deadline for facility and product registrations provides a welcome respite for the industry to prepare for compliance with MoCRA. However, the overall uncertainty persists, especially regarding regulations beyond registration, and businesses are advised to stay vigilant and prepare for the originally scheduled deadline of December 29, 2023.